1. Home
  2. AIRE vs GTBP Comparison

AIRE vs GTBP Comparison

Compare AIRE & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$1.36

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$7.16

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
GTBP
Founded
2021
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.0M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
AIRE
GTBP
Price
$1.36
$7.16
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$1.30
N/A
AVG Volume (30 Days)
88.1K
341.5K
Earning Date
04-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
3.75
EPS
N/A
N/A
Revenue
$4,518,498.00
N/A
Revenue This Year
$129.06
N/A
Revenue Next Year
$83.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
376.42
N/A
52 Week Low
$0.16
$0.22
52 Week High
$3.98
$11.98

Technical Indicators

Market Signals
Indicator
AIRE
GTBP
Relative Strength Index (RSI) 41.82 65.87
Support Level $1.29 $0.36
Resistance Level $1.85 N/A
Average True Range (ATR) 0.11 1.07
MACD -0.02 0.49
Stochastic Oscillator 26.53 59.43

Price Performance

Historical Comparison
AIRE
GTBP

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: